Skip to content

Read-only version: For security reasons, the Research Information System (FIS) has been temporarily replaced by this read-only version. All public content and full texts remain available; login, editing, submission and statistics are not available. Questions: fis@uni-bamberg.de

Home › Publications › Longitudinal associations between biomarkers of inflammation and changes in depressive symptoms in patients with type 1 and type 2 diabetes

Publication

Longitudinal associations between biomarkers of inflammation and changes in depressive symptoms in patients with type 1 and type 2 diabetes

Herder, Christian; Schmitt, Andreas; Budden, Florian; u. a. (2018): Longitudinal associations between biomarkers of inflammation and changes in depressive symptoms in patients with type 1 and type 2 diabetes, in: Psychoneuroendocrinology : an international journal ; the official journal of the International Society of Psychoneuroendocrinology, Amsterdam [u.a.]: Elsevier, Jg. 91, S. 216–225, doi: 10.1016/j.psyneuen.2018.02.032.

Details

Faculty/Chair
Author
Herder, Christian
Schmitt, Andreas
Budden, Florian
Reimer, André
Roden, Michael
Haak, Thomas
Title of the Journal
Psychoneuroendocrinology : an international journal ; the official journal of the International Society of Psychoneuroendocrinology
ISSN
0306-4530
Publisher Information
Elsevier : Amsterdam [u.a.]
Year of publication
2018
Volume
91
Language
English
DOI
URL
Abstract

Background: Depressive disorders represent a frequent comorbidity of type 1 diabetes (T1D) and type 2 diabetes (T2D). Subclinical inflammation increases the risk of depressive symptoms in the general population, but the relationship appears complex and bidirectional, and longitudinal data from patients with diabetes are lacking. Therefore, this study aimed to analyse associations between changes in depressive symptoms and changes in biomarkers of inflammation in patients with T1D and T2D and to investigate the hypothesis that higher baseline levels of biomarkers of inflammation are related to a less pronounced reduction of depressive symptoms over time.

Methods: Depressive symptoms and systemic levels of six biomarkers of inflammation were assessed in 168 individuals with T1D and 103 individuals with T2D who participated in baseline and 1-year follow-up examinations. Data were obtained from two matching randomised controlled trials addressing diabetes distress and depressive symptoms. Longitudinal associations between biomarkers and depressive symptoms were estimated using linear regression models adjusting for multiple confounders.

Results:In patients with T2D, reductions in depressive symptoms were associated with reductions in high-sensitivity C-reactive protein (hsCRP), interleukin (IL)-18 and IL-1 receptor antagonist (IL-1RA) (P ≤ 0.016), whereas no associations were seen for IL-6, CCL2 and adiponectin. Higher CCL2 levels at baseline were associated with lower subsequent reduction in depressive symptoms (P = 0.018). Neither baseline levels nor changes in biomarkers in subclinical inflammation were associated with changes in depressive symptoms in patients with T1D.

Conclusions: Reductions of depressive symptoms were longitudinally associated with reductions in biomarkers of inflammation in patients with T2D. Higher baseline CCL2 levels were related with lower reduction of depressive symptoms in this group. No such associations were observed in patients with T1D, suggesting that risk factors and pathomechanisms linking inflammation and depression may differ between diabetes types.

Keywords
Inflammation
Biomarkers
Type 1 diabetes
Type 2 diabetes
Depression
Peer Reviewed
yes
International Distribution
yes
Open Access Journal
no
Type
Article
URI
Activation date
2019-08-19, 2019-08-19

Permalink: https://fis.uni-bamberg.de/handle/uniba/46244 · Data as JSON · Cite: BibTeX · RIS

Data as of: 2026-11-16

Restricted read-only access: login, editing and submission are temporarily disabled.